Table 2 Angioirritative potential of antiseptics in long term application
Product™ | Substance | Reaction | Time [min] |
|---|---|---|---|
negative controls | |||
Rinsing solutions | 0,9% physiological saline, Ringer solution | no | 60 |
Buffered solution | PBS | no | 60 |
positive control | |||
1% SDS | Sodium dodecyl sulfat | severe | 5 |
solutions: | |||
Dettol™ | 0.35% chloroxylenol + 0.8% denaturated alcohol | severe | 5 |
Cutasept™ | 72% isopropanol | severe | 5 |
Octenisept™ | 0.1% octenidin - 2HCL | severe | 5 |
Betaisodona™ | 10% PVP-I | severe | 60 |
Betaisodona™ 1:10 | 1% PVP-I | severe | 60 |
Prontosan™ | 0.1% polyhexanid | severe | 60 |
Lavanid™ | 0.04% polyhexanid | no | 60 |
MDT | sterile washings from Lucilia sericata maggots | no | 60 |
Ointments, pellets | |||
Iruxol-n™ | Enzyme filtrations from Clostridium histolyticum | no | 5 |
Flammazine™ | 1% silver-sulfadiazine | slight | 5 |
Betaisodona™ ointment | 10% PVP-I | severe | 5 |
Repithel™ | 3% lysosomal PVP-I | moderate | 60 |
Iodosorb™ | 1,8% cadexomer-iodine | moderate | 60 |
Iodosorb™ Pellets | 1% cadexomer-iodine | moderate | 60 |